从无塑性贫血到血液恶性瘤的解开轨迹:遗传和分子洞察力
Namsoo Kim1, Yu Jeong Choi1, Seung-Tae Lee1,2
1Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Frontiers in oncology
|March 28, 2024
概括
无质性贫血可以发展为血液性恶性瘤. 基因分析揭示了单体7和PTPN11突变是这种进展的重要因素,突出了克隆进化.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 无形性贫血 (AA) 涉及到造血干细胞缺乏.
- AA可以转化为各种血液性恶性瘤.
- 这种转变的基因基础尚未完全理解.
研究的目的:
- 为了研究与获得的无塑性贫血向血液恶性瘤的进展相关的遗传变化.
- 识别潜在的遗传标记,以预测或理解这种转变.
主要方法:
- 对9名患有血性贫血患者的回顾性分析,这些患者患有血液性恶性瘤.
- 收集和分析临床,实验室,型和下一代测序 (NGS) 数据.
- 检查了染色体异常和突变概况.
主要成果:
- 七名患者患有骨髓质疏松症候群,一名患有急性骨髓性白血病,一名患有慢性骨髓单细胞性白血病.
- 在8名具有型数据的患者中,在3名患者中检测到单体7型.
- 在3名具有NGS数据的患者中,KMT2C突变在2名患者中被发现;在疾病进展过程中观察到PTPN11突变.
结论:
- 这项研究阐明了无塑性贫血进展到血液恶性瘤的遗传动力学.
- 单体7和PTPN11突变可能具有预测和预后价值.
- 克隆进化在疾病进展的复杂性中起着至关重要的作用.
相关概念视频
Bone Marrow Sampling and Transplants
328
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
328
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


